Squarepoint Ops LLC Nuvation Bio Inc. Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 230,997 shares of NUVB stock, worth $619,071. This represents 0.0% of its overall portfolio holdings.

Number of Shares

230,997

Holding current value

$619,071

% of portfolio

0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$2.3 - $3.83 $531,293 - $884,718	230,997 New	230,997 $531,000
Q1 2024 May 15, 2024	SELL	$1.46 - $3.97 $223,582 - $607,961	-153,139 Reduced 87.87%	21,138 $76,000
Q4 2023 Feb 14, 2024	BUY	$0.96 - $1.53 $114,396 - $182,319	119,163 Added 216.21%	174,277 $263,000
Q2 2023 Aug 14, 2023	SELL	$1.56 - $1.84 $29,750 - $35,090	-19,071 Reduced 25.71%	55,114 $99,000
Q1 2023 May 15, 2023	BUY	$1.6 - $2.48 $79,540 - $123,288	49,713 Added 203.14%	74,185 $123,000
Q4 2022 Feb 14, 2023	SELL	$1.68 - $2.5 $81,940 - $121,935	-48,774 Reduced 66.59%	24,472 $46,000
Q3 2022 Nov 14, 2022	SELL	$0.29 - $4.04 $5,395 - $75,164	-18,605 Reduced 20.26%	73,246 $164,000
Q2 2022 Aug 15, 2022	BUY	$3.24 - $5.85 $297,597 - $537,328	91,851 New	91,851 $298,000
Q2 2021 Aug 16, 2021	SELL	$9.22 - $14.48 $100,534 - $157,889	-10,904 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$9.0 - $14.57 $98,136 - $158,871	10,904 New	10,904 $114,000

Others Institutions Holding NUVB

# of Institutions

159

Shares Held

157M

Call Options Held

3.2K

Put Options Held

98.7K

Decheng Capital LLC Menlo Park, CA

26M
Shares

$69.6 Million
14.08% of portfolio
Eco R1 Capital, LLC San Francisco, CA

19.2M
Shares

$51.5 Million
1.92% of portfolio
Black Rock Inc. New York, NY

16.2M
Shares

$43.5 Million
0.0% of portfolio
Omega Fund Management, LLC Boston, MA

13.1M
Shares

$35 Million
44.61% of portfolio
Octagon Capital Advisors LP New York, NY

12.2M
Shares

$32.6 Million
6.76% of portfolio

View Full List

About Nuvation Bio Inc.

Ticker NUVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 217,244,000
Market Cap $582M
Description
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...

More about NUVB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account